METHOD FOR DIAGNOSING SEPTIC PROCESS AND PREDICTING SEPTIC COMPLICATIONS DEVELOPMENT IN CHILDREN
FIELD: medicine. ^ SUBSTANCE: method involves determining plasminogen/plasmin, alpha2-macro-globulin, alpha1-antitripsin content at the first, third, fifth and tenth day. The plasminogen/plasmin level being equal to 66-74 mcmole/l or 100-120 mcmole/l, alpha2-macro-globulin level of 2.7-3.0 mcmole/l,...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: method involves determining plasminogen/plasmin, alpha2-macro-globulin, alpha1-antitripsin content at the first, third, fifth and tenth day. The plasminogen/plasmin level being equal to 66-74 mcmole/l or 100-120 mcmole/l, alpha2-macro-globulin level of 2.7-3.0 mcmole/l, alpha1-antitripsin content of 2.38-3.2 mcmole/l, systemic inflammatory response to purulent infection, light severity degree endotoxicosis is diagnosed and favorable disease outcome is predicted. The plasminogen/plasmin level being equal to 50-65 mcmole/l or 125-160 mcmole/l, alpha2-macro-globulin level of 2.3-2.6 mcmole/l, alpha1-antitripsin content of 3.3-4.0 mcmole/l, sepsis with organ and system dysfunction, moderate severity degree endotoxicosis is diagnosed and septic complication availability and lingering disease development course is predicted. The plasminogen/plasmin level being equal to 39-40 mcmole/l, alpha2-macro-globulin level of 1.58-2.08 mcmole/l, alpha1-antitripsin content of 5.0-6.2 mcmole/l, severe sepsis, septic shock, severe degree endotoxicosis is diagnosed and unfavorable disease outcome is predicted. ^ EFFECT: high accuracy of diagnosis. ^ 5 tbl |
---|